A Problem for Every Drug Isn’t it curious how something is barely noticed until a drug is created for it? Then it becomes an epidemic. Take what started out as “female sexual interest/arousal disorder” in DSM-5 in 2013. Fancy that! Two years later, a drug — Boehringer-Ingelheim’s Flibanserin (Addyi™) — was created for it, after…